Compounds > l 158809
Page last updated: 2024-09-03

l 158809 and 1h-imidazo(4,5-b)pyridine

l 158809 has been researched along with 1h-imidazo(4,5-b)pyridine in 1 studies

Compound Research Comparison

Studies
(l 158809)		Trials
(l 158809)		Recent Studies (post-2010)
(l 158809)		Studies
(1h-imidazo(4,5-b)pyridine)		Trials
(1h-imidazo(4,5-b)pyridine)		Recent Studies (post-2010) (1h-imidazo(4,5-b)pyridine)
13707100087

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chakravarty, PK; Chang, RS; Chen, TB; Faust, KA; Lotti, VJ; Mantlo, NB; Ondeyka, DL; Schorn, TW; Siegl, PK; Sweet, CS1

Other Studies

1 other study(ies) available for l 158809 and 1h-imidazo(4,5-b)pyridine

ArticleYear
Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonists.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:9

    Topics: Administration, Oral; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Imidazoles; Purines; Rats; Tetrazoles

1991